![Søren Morgenthaler Echwald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Søren Morgenthaler Echwald
Chief Executive Officer at Anapa Biotech A/S
Søren Morgenthaler Echwald active positions
Companies | Position | Start | End |
---|---|---|---|
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Chief Executive Officer | - | - |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Director/Board Member | - | - |
Career history of Søren Morgenthaler Echwald
Former positions of Søren Morgenthaler Echwald
Companies | Position | Start | End |
---|---|---|---|
EXIQON A/S | Corporate Officer/Principal | - | - |
Statistics
International
Denmark | 4 |
Operational
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectoral
Commercial Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Exiqon A/S
![]() Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Anapa Biotech A/S
![]() Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Commercial Services |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |